Browsing by author "Cuesta Llavona, Elías"

Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome

Gómez de Oña, Juan

; Muñiz Albaiceta, Guillermo

; García Clemente, Marta María

; López Larrea, Carlos

; Amado Rodríguez, Laura

; López Alonso, Inés

; Hermida, T.; Enríquez Rodríguez, Ana Isabel; Herrero, P.; Melón García, Santiago

; Alvarez Argüelles, Marta Elena; Boga Riveiro, José Antonio; Rojo Alba, S.; Cuesta Llavona, Elías; Alvarez, V.; Lorca Gutiérrez, Rebeca

; Coto García, Eliecer

(2020)

Association of the genetic variation in the long non‐coding RNA FENDRR with the risk of developing hypertrophic cardiomyopathy

Cuesta Llavona, Elías; Lorca, R.; Rolle, V.; Alonso, B.; Iglesias, S.; Rodríguez Reguero, José Julián

; Duarte Herrera, I. D.; Pérez Oliveira, S.; Junco Vicente, Alejandro; García Lago, Claudia; Coto García, Eliecer

; Gómez de Oña, Juan

(2022)

Capillary electrophoresis of PCR fragments with 5´-labelled primers for testing the SARS-Cov-2

Gómez de Oña, Juan

; Melón García, Santiago

; Boga Riveiro, José Antonio; Álvarez Argüelles, Marta Elena; Rojo Alba, Susana; Leal Negredo, Álvaro; Castelló Abietar, Cristian; Álvarez, V.; Cuesta Llavona, Elías; Coto García, Eliecer

(2020)

Characterization of left ventricular non-compaction cardiomyopathy

Lorca Gutiérrez, Rebeca

; Martín Fernández, María

; Pascual Calleja, Isaac

; Astudillo González, María Aurora

; Díaz Molina, Beatriz

; Cigarrán, Helena; Cuesta Llavona, Elías; Avanzas Fernández, Pablo

; Rodríguez Reguero, José Julián

; Coto García, Eliecer

; Morís de la Tassa, César

; Gómez de Oña, Juan

(2020)

Chromosome Y haplogroup R was associated with the risk of premature myocardial infarction with ST-elevation: data from the choleSTEMI registry

Lorca Gutiérrez, Rebeca

; Aparicio, A.; Salgado, M.; Álvarez Velasco, Rut; Pascual Calleja, Isaac

; Gómez, J.; Vázquez Coto, D.; García Lago, C.; Velázquez Cuervo, L.; Cuesta Llavona, Elías; Avanzas Fernández, Pablo

; Coto García, Eliecer

(2023)

Clinical evaluation of patients with genetically confirmed familial hypercholesterolemia

Aparicio, A.; Villazón Gónzález, Francisco

; Suárez Gutiérrez, L.; Gómez, J.; Martínez Faedo, C.; Méndez Torre, E.; Avanzas Fernández, Pablo

; Álvarez Velasco, R.; Cuesta Llavona, Elías; García Lago, C.; Neuhalfen, D.; Coto García, Eliecer

; Lorca, R. (2023)

Common mitochondrial haplogroups as modifiers of the onset-age for critical COVID-19

Vázquez Coto, Daniel; Muñiz Albaiceta, Guillermo

; Amado Rodríguez, Laura

; Clemente, M. G.; Cuesta Llavona, Elías; Gómez, J.; Coto García, Eliecer

(2022)

Compound heterozygosity for PTPN11 variants in a subject with Noonan syndrome provides insights into the mechanism of SHP2-related disorders

Lorca Gutiérrez, Rebeca

; Pannone, L.; Cuesta Llavona, Elías; Bocchinfuso, G.; Rodríguez Reguero, José Julián

; Carpentieri, G.; Hernando, Inés; Flex, E.; Tartaglia, M.; Coto García, Eliecer

; Gómez, Juan; Martinelli, S. (2021)

Furin gene variants (rs6224/rs4702) as potential markers of death and cardiovascular traits in severe COVID-19

Coto García, Eliecer

; Muñiz Albaiceta, Guillermo

; Amado Rodríguez, Laura

; García Clemente, Marta María

; Cuesta Llavona, Elías; Vázquez Coto, Daniel; Alonso González, Belén

; Iglesias, Sara; Melón García, Santiago

(2022)

Gene Variant in the NF- κ B Pathway Inhibitor NFKBIA Distinguishes Patients with Psoriatic Arthritis within the Spectrum of Psoriatic Disease

Coto Segura, Pablo

; Coto García, Eliecer

; González Lara, Leire; Alonso, Belén; Gómez, Juan; Cuesta Llavona, Elías; Queiro Silva, Rubén

(2019)

Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and risk for early-onset coronary artery disease

Coto García, Eliecer

; Rodríguez Reguero, José Julián

; Avanzas Fernández, Pablo

; Pascual Calleja, Isaac

; Martín, M.; Hevia Nava, Sergio

; Morís de la Tassa, César

; Díaz Molina, Beatriz

; Rodríguez Lambert, José Luis

; Alonso González, Belén

; Cuesta Llavona, Elías; Díaz Corte, María del Carmen

; Gómez, Juan (2019)

Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients

Camblor, D. G.; Miranda, D.; Muñiz Albaiceta, Guillermo

; Amado Rodríguez, Laura

; Cuesta Llavona, Elías; Vázquez Coto, D.; Gómez de Oña, J.; García Lago, C.; Muñoz Gómez, J.; Coto García, Eliecer

(2022)

IGHG3 hinge length variation was associated with the risk of critical disease and death in a Spanish COVID-19 cohort

López Martínez, R.; Muñiz Albaiceta, Guillermo

; Amado Rodríguez, Laura

; Gómez de Oña, Juan

; Cuesta Llavona, Elías; García Clemente, Marta María

; Hermida Valverde, T.; Enríquez Rodríguez, A. I.; Hernández González, C.; Martínez Borra, Jesús

; López Larrea, Carlos

; Gil Peña, Helena

; Álvarez Martínez, María Victoria

; Coto García, Eliecer

(2022)

IL17RA in early-onset coronary artery disease: total leukocyte transcript analysis and promoter polymorphism (rs4819554) association

Coto García, Eliecer

; Pascual Calleja, Isaac

; Avanzas Fernández, Pablo

; Cuesta Llavona, Elías; Lorca Gutiérrez, Rebeca

; Martín, María; Vázquez Coto, Daniel; Díaz Corte, María del Carmen

; Morís de la Tassa, César

; Rodríguez Reguero, José Julián

; Gómez, Juan (2020)

Mitochondrial heteroplasmy as a marker for premature coronary artery disease: analysis of the poly-C tract of the control region sequence

Lorca Gutiérrez, Rebeca

; Aparicio, A.; Gómez, Juan; Álvarez Velasco, Rut; Pascual Calleja, Isaac

; Avanzas Fernández, Pablo

; González Urbistondo, F.; Alen, A.; Vázquez Coto, D.; González Fernández, M.; García Lago, C.; Cuesta Llavona, Elías; Morís de la Tassa, César

; Coto García, Eliecer

(2023)

Opportunistic genetic screening for familial hypercholesterolemia in heart transplant patients

Salgado, María; Díaz Molina, Beatriz

; Cuesta Llavona, Elías; Aparicio, A.; Fernández, M.; Alonso, V.; Avanzas Fernández, Pablo

; Pascual Calleja, Isaac

; Neuhalfen, David; Coto García, Eliecer

; Gómez, J.; Lorca, R. (2023)

The APOB polymorphism rs1801701 A/G (p.R3638Q) is an independent risk factor for early-onset coronary artery disease: data from a Spanish cohort

Coto García, Eliecer

; Lorca Gutiérrez, Rebeca

; Rodríguez Reguero, José Julián

; Martín Fernández, María

; Pascual Calleja, Isaac

; Avanzas Fernández, Pablo

; Cuesta Llavona, Elías; Vázquez Coto, Daniel; Díaz Corte, C.; Tranche, S.; Alonso, B.; Iglesias, S.; Morís de la Tassa, César

; Gómez, Juan (2021)

The FCGR2A rs1801274 polymorphism was associated with the risk of death among COVID-19 patients

López Martínez, Rocío; Muñiz Albaiceta, Guillermo

; Amado Rodríguez, Laura

; Cuesta Llavona, Elías; Gómez, Juan; García Clemente, Marta María

; Vázquez Coto, Daniel; Álvarez, V.; Coto García, Eliecer

(2022)

The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19

Gómez, Juan; Muñiz Albaiceta, Guillermo

; Cuesta Llavona, Elías; García Clemente, Marta María

; López Larrea, Carlos

; Amado Rodríguez, Laura

; López Alonso, Inés

; Melón García, Santiago

; Alvarez Argüelles, Marta Elena; Gil Peña, Helena

; Vidal Castiñeira, José Ramón

; Corte Iglesias, V.; Saiz, M. L.; Alvarez, V.; Coto García, Eliecer

(2021)

Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity

Cuesta Llavona, Elías; Gómez de Oña, Juan

; Muñiz Albaiceta, Guillermo

; Amado Rodríguez, Laura

; García Clemente, Marta María

; Gutiérrez Rodríguez, J.; López Alonso, Inés

; Hermida, T.; Enríquez Rodríguez, Ana Isabel; Hernández González, Cristina; Gil Peña, Helena

; Domínguez Garrido, E.; Pérez Oliveira, S.; Álvarez Martínez, María Victoria

; López Larrea, Carlos

; Suárez Álvarez, Beatriz

; Tranche Iparraguirre, Salvador

; Jimeno Demuth, F. J.; Coto García, Eliecer

(2021)

Browsing by author "Cuesta Llavona, Elías"

Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome ﻿

Association of the genetic variation in the long non‐coding RNA FENDRR with the risk of developing hypertrophic cardiomyopathy ﻿

Capillary electrophoresis of PCR fragments with 5´-labelled primers for testing the SARS-Cov-2 ﻿

Characterization of left ventricular non-compaction cardiomyopathy ﻿

Chromosome Y haplogroup R was associated with the risk of premature myocardial infarction with ST-elevation: data from the choleSTEMI registry ﻿

Clinical evaluation of patients with genetically confirmed familial hypercholesterolemia ﻿

Common mitochondrial haplogroups as modifiers of the onset-age for critical COVID-19 ﻿

Compound heterozygosity for PTPN11 variants in a subject with Noonan syndrome provides insights into the mechanism of SHP2-related disorders ﻿

Furin gene variants (rs6224/rs4702) as potential markers of death and cardiovascular traits in severe COVID-19 ﻿

Gene Variant in the NF- κ B Pathway Inhibitor NFKBIA Distinguishes Patients with Psoriatic Arthritis within the Spectrum of Psoriatic Disease ﻿

Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and risk for early-onset coronary artery disease ﻿

Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients ﻿

IGHG3 hinge length variation was associated with the risk of critical disease and death in a Spanish COVID-19 cohort ﻿

IL17RA in early-onset coronary artery disease: total leukocyte transcript analysis and promoter polymorphism (rs4819554) association ﻿

Mitochondrial heteroplasmy as a marker for premature coronary artery disease: analysis of the poly-C tract of the control region sequence ﻿

Opportunistic genetic screening for familial hypercholesterolemia in heart transplant patients ﻿

The APOB polymorphism rs1801701 A/G (p.R3638Q) is an independent risk factor for early-onset coronary artery disease: data from a Spanish cohort ﻿

The FCGR2A rs1801274 polymorphism was associated with the risk of death among COVID-19 patients ﻿

The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19 ﻿

Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity ﻿

Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome

Association of the genetic variation in the long non‐coding RNA FENDRR with the risk of developing hypertrophic cardiomyopathy

Capillary electrophoresis of PCR fragments with 5´-labelled primers for testing the SARS-Cov-2

Characterization of left ventricular non-compaction cardiomyopathy

Chromosome Y haplogroup R was associated with the risk of premature myocardial infarction with ST-elevation: data from the choleSTEMI registry

Clinical evaluation of patients with genetically confirmed familial hypercholesterolemia

Common mitochondrial haplogroups as modifiers of the onset-age for critical COVID-19

Compound heterozygosity for PTPN11 variants in a subject with Noonan syndrome provides insights into the mechanism of SHP2-related disorders

Furin gene variants (rs6224/rs4702) as potential markers of death and cardiovascular traits in severe COVID-19

Gene Variant in the NF- κ B Pathway Inhibitor NFKBIA Distinguishes Patients with Psoriatic Arthritis within the Spectrum of Psoriatic Disease

Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and risk for early-onset coronary artery disease

Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients

IGHG3 hinge length variation was associated with the risk of critical disease and death in a Spanish COVID-19 cohort

IL17RA in early-onset coronary artery disease: total leukocyte transcript analysis and promoter polymorphism (rs4819554) association

Mitochondrial heteroplasmy as a marker for premature coronary artery disease: analysis of the poly-C tract of the control region sequence

Opportunistic genetic screening for familial hypercholesterolemia in heart transplant patients

The APOB polymorphism rs1801701 A/G (p.R3638Q) is an independent risk factor for early-onset coronary artery disease: data from a Spanish cohort

The FCGR2A rs1801274 polymorphism was associated with the risk of death among COVID-19 patients

The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19

Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity